Filing Details

Accession Number:
0001127602-24-020038
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-03 15:04:14
Reporting Period:
2024-07-01
Accepted Time:
2024-07-03 15:04:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1531048 Inari Medical Inc. NARI Surgical & Medical Instruments & Apparatus (3841) 452902923
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1806431 Andrew Hykes C/O Inari Medical, Inc.
6001 Oak Canyon
Irvine CA 92618
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-07-01 3,000 $50.08 462,474 No 4 S Direct
Common Stock Disposition 2024-07-01 508 $50.19 461,966 No 4 F Direct
Common Stock Disposition 2024-07-01 947 $50.19 461,019 No 4 F Direct
Common Stock Disposition 2024-07-01 1,475 $50.19 459,544 No 4 F Direct
Common Stock Disposition 2024-07-01 1,292 $50.19 458,252 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 F Direct
No 4 F Direct
No 4 F Direct
No 4 F Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,550 Indirect By Child 1
Common Stock 1,550 Indirect By Child 2
Common Stock 1,550 Indirect By Child 3
Common Stock 1,000 Indirect By Spouse
Footnotes
  1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023.
  2. This transaction was executed in multiple trades at prices ranging from $50.00 to $50.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021.
  4. Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022.
  5. Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2023.
  6. Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2024.